• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

颅内动脉粥样硬化疾病的动脉病变位置与预后

Arterial Lesion Location and Outcomes of Intracranial Atherosclerotic Disease.

作者信息

Tariq Muhammad Bilal, Kaneko Naoki, Prochilo Grace, Hinman Jason D, Liebeskind David S

机构信息

UCLA Comprehensive Stroke Center, Department of Neurology, University of California, Los Angeles, CA, USA.

Division of Interventional Neuroradiology, Department of Radiological Sciences, University of California, Los Angeles, CA, USA.

出版信息

Stroke Vasc Interv Neurol. 2024 Sep;4(5). doi: 10.1161/SVIN.124.001344. Epub 2024 Apr 23.

DOI:10.1161/SVIN.124.001344
PMID:39429512
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11488790/
Abstract

Intracranial atherosclerosis is a leading cause of stroke with a high recurrence rate despite treatment. Numerous factors are proposed to influence stroke recurrence due to intracranial atherosclerosis including lesion eccentricity, plaque characteristics, and computational fluid dynamic metrics, such as wall shear stress. An overlooked variable that intrinsically relates to intracranial atherosclerosis is the location of the arterial segment where the lesion occurs. Variations in cerebral blood flow, arterial anatomy, and flow dynamics are likely drivers of initial lesion development and thus likely to influence stroke recurrence. To date, treatment trials of intracranial atherosclerosis have not considered arterial segment lesion location as an independent variable, failing to account for variations in flow dynamics between each artery. There are limited available data on differences between arterial segments, confined to only analyses. In this review, we summarize available data on such differences between arterial segments. With the limited arterial segment data available, multiple differences in recurrence of stroke in territory of lesion were identified across trials.

摘要

颅内动脉粥样硬化是中风的主要原因,尽管进行了治疗,但复发率仍很高。许多因素被认为会影响颅内动脉粥样硬化导致的中风复发,包括病变偏心度、斑块特征以及计算流体动力学指标,如壁面剪应力。一个与颅内动脉粥样硬化内在相关但被忽视的变量是病变发生的动脉节段位置。脑血流量、动脉解剖结构和血流动力学的变化可能是初始病变发展的驱动因素,因此可能影响中风复发。迄今为止,颅内动脉粥样硬化的治疗试验尚未将动脉节段病变位置作为一个独立变量,未能考虑各动脉之间血流动力学的差异。关于动脉节段之间差异的可用数据有限,仅限于仅有的分析。在本综述中,我们总结了关于动脉节段之间此类差异的可用数据。由于可用的动脉节段数据有限,在各项试验中发现了病变区域中风复发的多个差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca10/12778553/61594c58481e/SVI2-4-e001344-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca10/12778553/d089309060b8/SVI2-4-e001344-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca10/12778553/61594c58481e/SVI2-4-e001344-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca10/12778553/d089309060b8/SVI2-4-e001344-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca10/12778553/61594c58481e/SVI2-4-e001344-g002.jpg

相似文献

1
Arterial Lesion Location and Outcomes of Intracranial Atherosclerotic Disease.颅内动脉粥样硬化疾病的动脉病变位置与预后
Stroke Vasc Interv Neurol. 2024 Sep;4(5). doi: 10.1161/SVIN.124.001344. Epub 2024 Apr 23.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Thrombolysis for acute ischaemic stroke.急性缺血性脑卒中的溶栓治疗
Cochrane Database Syst Rev. 2003(3):CD000213. doi: 10.1002/14651858.CD000213.
4
Carotid Artery Surgery颈动脉手术
5
Variations in intracranial arterial anatomy of the circle of Willis and their association with arteriosclerosis in patients with ischemic cerebrovascular disease.缺血性脑血管病患者 Willis 环颅内动脉解剖变异及其与动脉硬化的关系。
Int J Stroke. 2025 Feb 27:17474930251322678. doi: 10.1177/17474930251322678.
6
Automated devices for identifying peripheral arterial disease in people with leg ulceration: an evidence synthesis and cost-effectiveness analysis.用于识别下肢溃疡患者外周动脉疾病的自动化设备:证据综合和成本效益分析。
Health Technol Assess. 2024 Aug;28(37):1-158. doi: 10.3310/TWCG3912.
7
Type of anaesthesia for acute ischaemic stroke endovascular treatment.急性缺血性脑卒中血管内治疗的麻醉类型。
Cochrane Database Syst Rev. 2022 Jul 20;7(7):CD013690. doi: 10.1002/14651858.CD013690.pub2.
8
Endovascular thrombectomy with versus without intravenous thrombolysis for acute ischaemic stroke.急性缺血性卒中血管内血栓切除术联合与不联合静脉溶栓治疗的比较
Cochrane Database Syst Rev. 2025 Apr 24;4(4):CD015721. doi: 10.1002/14651858.CD015721.pub2.
9
Infusion techniques for peripheral arterial thrombolysis.外周动脉溶栓的输注技术。
Cochrane Database Syst Rev. 2021 Nov 17;11(11):CD000985. doi: 10.1002/14651858.CD000985.pub3.
10
Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis.氯吡格雷和双嘧达莫缓释制剂预防闭塞性血管事件(技术评估 90 号回顾):系统评价和经济分析。
Health Technol Assess. 2011 Sep;15(31):1-178. doi: 10.3310/hta15310.

引用本文的文献

1
Propensity score matched analysis of nationwide outcomes for intracranial bypass and stenting for treatment of intracranial atherosclerotic disease.颅内搭桥术和支架置入术治疗颅内动脉粥样硬化疾病的全国性结局的倾向评分匹配分析。
Sci Rep. 2025 Jul 29;15(1):27577. doi: 10.1038/s41598-025-12594-3.
2
Differential Pattern of Circulating MicroRNA Expression in Patients with Intracranial Atherosclerosis.颅内动脉粥样硬化患者循环微小RNA表达的差异模式
Biomedicines. 2025 Feb 19;13(2):514. doi: 10.3390/biomedicines13020514.

本文引用的文献

1
Impact of qualifying artery on the efficacy of stenting plus medical therapy versus medical therapy alone in patients with symptomatic intracranial stenosis: a post-hoc analysis of the CASSISS trial.症状性颅内狭窄患者支架置入联合药物治疗与单纯药物治疗疗效的影响因素:CASSISS 试验的事后分析。
J Neurointerv Surg. 2024 Jun 17;16(7):663-669. doi: 10.1136/jnis-2023-020456.
2
Wall Shear Stress Associated with Stroke Occurrence and Mechanisms in Middle Cerebral Artery Atherosclerosis.大脑中动脉粥样硬化中与中风发生及机制相关的壁面剪应力
J Stroke. 2023 Jan;25(1):132-140. doi: 10.5853/jos.2022.02754. Epub 2023 Jan 31.
3
Chronic remote ischaemic conditioning in patients with symptomatic intracranial atherosclerotic stenosis (the RICA trial): a multicentre, randomised, double-blind sham-controlled trial in China.
症状性颅内动脉粥样硬化狭窄患者的慢性远程缺血预处理(RICA 试验):中国多中心、随机、双盲假手术对照试验。
Lancet Neurol. 2022 Dec;21(12):1089-1098. doi: 10.1016/S1474-4422(22)00335-0. Epub 2022 Oct 27.
4
Effect of Stenting Plus Medical Therapy vs Medical Therapy Alone on Risk of Stroke and Death in Patients With Symptomatic Intracranial Stenosis: The CASSISS Randomized Clinical Trial.支架置入联合药物治疗与单纯药物治疗对症状性颅内狭窄患者卒中和死亡风险的影响:CASSISS 随机临床试验。
JAMA. 2022 Aug 9;328(6):534-542. doi: 10.1001/jama.2022.12000.
5
HR-MRI findings of intracranial artery stenosis and distribution of atherosclerotic plaques caused by different etiologies.颅内动脉狭窄的 HR-MRI 表现及不同病因所致粥样硬化斑块分布
Neurol Sci. 2022 Sep;43(9):5421-5430. doi: 10.1007/s10072-022-06132-6. Epub 2022 May 26.
6
Comparison of Drug-Eluting Stent With Bare-Metal Stent in Patients With Symptomatic High-grade Intracranial Atherosclerotic Stenosis: A Randomized Clinical Trial.药物洗脱支架与裸金属支架治疗症状性颅内动脉粥样硬化狭窄程度高的患者比较:一项随机临床试验。
JAMA Neurol. 2022 Feb 1;79(2):176-184. doi: 10.1001/jamaneurol.2021.4804.
7
Dual Antiplatelet Therapy Using Cilostazol in Patients With Stroke and Intracranial Arterial Stenosis.使用西洛他唑的双重抗血小板疗法治疗卒中和颅内动脉狭窄患者。
J Am Heart Assoc. 2021 Oct 19;10(20):e022575. doi: 10.1161/JAHA.121.022575. Epub 2021 Oct 8.
8
Infarct Recurrence in Intracranial Atherosclerosis: Results from the MyRIAD Study.颅内动脉粥样硬化性梗死复发:来自 MyRIAD 研究的结果。
J Stroke Cerebrovasc Dis. 2021 Feb;30(2):105504. doi: 10.1016/j.jstrokecerebrovasdis.2020.105504. Epub 2020 Dec 1.
9
The WOVEN trial: Wingspan One-year Vascular Events and Neurologic Outcomes.WOVEN 试验:Wingspan 一年血管事件和神经结局。
J Neurointerv Surg. 2021 Apr;13(4):307-310. doi: 10.1136/neurintsurg-2020-016208. Epub 2020 Jun 19.
10
Intensive Statin Treatment in Acute Ischaemic Stroke Patients with Intracranial Atherosclerosis: a High-Resolution Magnetic Resonance Imaging study (STAMINA-MRI Study).颅内动脉粥样硬化急性缺血性脑卒中患者的强化他汀治疗:高分辨率磁共振成像研究(STAMINA-MRI 研究)。
J Neurol Neurosurg Psychiatry. 2020 Feb;91(2):204-211. doi: 10.1136/jnnp-2019-320893. Epub 2019 Aug 1.